Health Condition 1: null- Subjects with mild to moderate Psoriasis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Informed Signed consent form 2 Patients aged 18 to 65 years 3 Patients with Mild to moderate Psoriasis
Exclusion criteria
Exclusion criteria: 1 Patients who have more than 50 percent of body surface area covered by psoriasis lesions 2 Patients on anticoagulant therapy 3 Use of immunosuppressive medication within past 2 month 4 Presence of other skin lesions like actinic ketoses or lentigo or photo damaged skin 5 Use of systemic or intralesional therapy or photo therapy for psoriasis in the previous Two months 6 Concomitant bacterial or fungal or viral skin infections 7 Pregnant or sexually active women who do not use contraception 8 Non-adherence to the treatment 9 Have history of renal or hepotobilary or malignant disease or hypertension or recurrent acute infection 10 History of any other evidence of severe illness or any other conditions that would make the patient in the opinion of the investigator unsuitable for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Extent of clearance of lesion Relief of symptoms Timepoint: Reduction in PASI Score Clinical Photographs Reduction in Biomarkers Global Evaluation by Doctor and Patient | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety ProfileTimepoint: Change in Laboratory Parameters Adverse Events | — |
Countries
India
Contacts
ClinWorld(P)Ltd.